Antisense Pharma GmbH raised €27 million (US$39.5 million) in a third investment round funded solely by MIG AG, which also was the only investor in its €18 million funding round two years ago. (BioWorld International)

GPC Biotech AG emerged successfully from its legal dispute with partner Spectrum Pharmaceuticals Inc., although the circumstances surrounding the case altered radically in the interim. (BioWorld International)

GPC Biotech AG emerged successfully from its legal dispute with partner Spectrum Pharmaceuticals Inc., although the circumstances surrounding the case altered radically in the interim. (BioWorld International)